Zhang L, Meng F T, Wu J N, Sui L, Cong Q
Cervical Disease Center, Obstetrics and Gynecology Hospital of Fudan University, Shanghai200011, China.
Department of Gynecology, The People's Hospital of Suzhou New District, Suzhou215129, China.
Zhonghua Fu Chan Ke Za Zhi. 2024 Nov 25;59(11):848-855. doi: 10.3760/cma.j.cn112141-20240725-00414.
To explore the value of CO laser therapy, photodynamic therapy, and follow-up observation in the management of cervical low-grade squamous intraepithelial lesion (LSIL). Women diagnosed with cervical LSIL and high risk human papillomavirus (HR-HPV) infection through colposcopy-guided biopsy from January 1, 2021 to December 31, 2023 were collected. According to a 1∶1 ratio, 107 cases were included in each of the laser treatment, photodynamic therapy, and follow-up groups. The complete remission rate and HR-HPV clearance rate were compared during the 6-12 months follow-up period. (1) Comparison of clinical data among the three groups before treatment: the median age of the 321 patients was (34.9±8.1) years. Before treatment, cytological abnormalities were present in 51.7% (166/321) of patients, and 35.2% (113/321) had human papillomavirus (HPV) 16/18 infections. The accuracy rate of colposcopic diagnosis was 69.2% (222/321). Age, cytology results, HPV 16/18 infection, and colposcopy diagnosis in the laser group, photodynamic group, and follow-up group were compared, and there were not statistically significant differences (all >0.05). (2) During the 6-12 months follow-up period, the complete remission rate was 89.7% (96/107) in the laser group, slightly higher than the 86.9% (93/107) in the photodynamic group, with no statistical difference between the two groups (=0.41, =0.523). However, both were significantly higher than the 64.5% (69/107) in the follow-up group (=19.30, <0.001; =14.63, <0.001). The HR-HPV clearance rates in the laser and photodynamic groups were 73.8% (79/107) and 68.2% (73/107), respectively, both significantly higher than the 32.7% (35/107) in the follow-up group (=36.34, <0.001; =26.99, <0.001), but with no statistical difference between the laser and photodynamic groups (=0.82, =0.366). CO laser therapy and photodynamic therapy are effective treatments for cervical LSIL, significantly superior to follow-up observation in terms of lesion remission and HR-HPV clearance rates. Individualized treatment plans could be developed based on the patient's age, duration of HR-HPV infection, colposcopic impression, and economic conditions.
探讨CO激光治疗、光动力治疗及随访观察在宫颈低度鳞状上皮内病变(LSIL)管理中的价值。收集2021年1月1日至2023年12月31日期间经阴道镜引导下活检诊断为宫颈LSIL且LSIL且合并高危型人乳头瘤病毒(HR-HPV)感染的女性患者。按照1∶1的比例,将患者分为激光治疗组、光动力治疗组和随访观察组,每组各107例。比较6-12个月随访期内的完全缓解率和HR-HPV清除率。(1)三组治疗前临床资料比较:321例患者的中位年龄为(34.9±8.1)岁。治疗前,51.7%(166/321)的患者存在细胞学异常,35.2%(113/321)的患者感染人乳头瘤病毒(HPV)16/18。阴道镜诊断准确率为69.2%(222/321)。比较激光组、光动力组和随访观察组的年龄、细胞学结果、HPV 16/18感染情况及阴道镜诊断结果,差异均无统计学意义(均>0.05)。(2)在6-12个月随访期内,激光组的完全缓解率为89.7%(96/107),略高于光动力组的86.9%(93/107),两组比较差异无统计学意义(=0.41,=0.523)。然而,两者均显著高于随访观察组的64.5%(69/107)(=19.30,<0.001;=14.63,<0.001)。激光组和光动力组的HR-HPV清除率分别为73.8%(79/107)和68.2%(73/107),均显著高于随访观察组的32.7%(35/107)(=36.34,<0.001;=·26.99,<0.001),但激光组与光动力组之间差异无统计学意义(=0.82,=0.366)。CO激光治疗和光动力治疗是治疗宫颈LSIL的有效方法,在病变缓解率和HR-HPV清除率方面显著优于随访观察。可根据患者年龄、HR-HPV感染持续时间、阴道镜印象及经济状况制定个体化治疗方案。